Tag: Patent Review
-
Invention for Antigen binding molecules for tigit
Invented by Ramesh R. Bhatt, Todd Kinsella, Wei Li, Rigel Pharmaceuticals Inc The market for antigen binding molecules for TIGIT (T cell immunoreceptor with Ig and ITIM domains) is rapidly growing as researchers and pharmaceutical companies recognize the potential of targeting this immune checkpoint pathway for cancer immunotherapy. TIGIT is a protein receptor found on…
-
Invention for Vista modulators to diagnose and treat cancer
Invented by Randolph Noelle, Kings College London, Dartmouth College The market for Vista modulators to diagnose and treat cancer has been rapidly growing in recent years. Vista modulators are a class of drugs that target the Vista protein, which plays a crucial role in regulating the immune response. By modulating the activity of Vista, these…
-
Invention for Packaging Method to Enable Re-sterilization Of Medical Device
Invented by Di Lu, Adam Zerda, Becton Dickinson and Co The market for packaging methods to enable re-sterilization of medical devices is experiencing significant growth due to the increasing demand for cost-effective and sustainable solutions in the healthcare industry. With the rising prevalence of healthcare-associated infections (HAIs) and the need for efficient sterilization processes, the…
-
Invention for Medical radiation device
Invented by Jian Liu, Jian Zhang, Yuelin SHAO, Shanghai United Imaging Healthcare Co Ltd The market for medical radiation devices has witnessed significant growth in recent years, driven by advancements in technology, increasing prevalence of chronic diseases, and rising demand for early diagnosis and treatment options. Medical radiation devices play a crucial role in various…
-
Invention for Medical devices for the application of bolster material and methods to apply them
Invented by Michael C. Hiles, Umesh H. Patel, Bhavin Shah, Chad S. McAlexander, Cook Biotech Inc The market for medical devices used for the application of bolster material and the methods to apply them has witnessed significant growth in recent years. Bolster materials are widely used in various medical procedures to provide support, protection, and…
-
Invention for Medical 3D (3D) Scanning and Mapping System
Invented by Hakki Refai, Badia Koudsi, Optecks LLC The market for Medical 3D Scanning and Mapping Systems has been experiencing significant growth in recent years. These advanced technologies have revolutionized the healthcare industry by providing accurate and detailed 3D images of the human body, enabling healthcare professionals to diagnose and treat patients more effectively. Medical…
-
Invention for Container and Set for Making the Same
Invented by Nicholas Herling, Marc Heinke The market for containers and sets for making the same has experienced significant growth in recent years. As people become more conscious of their environmental impact and strive to reduce waste, reusable containers have become increasingly popular. Additionally, the rise of the zero-waste movement and the increasing number of…
-
Invention for Antibody Therapeutics that Bind CTLA4
Invented by John Dixon Gray, Heyue Zhou, Sorrento Therapeutics Inc The market for antibody therapeutics that bind CTLA4, also known as cytotoxic T-lymphocyte-associated protein 4, is experiencing significant growth and is expected to continue expanding in the coming years. CTLA4 is a protein receptor found on the surface of T-cells, a type of white blood…
-
Invention for Antibody Therapeutics that Bind CD47
Invented by Barbara A. Swanson, John Dixon Gray, Heyue Zhou, Sorrento Therapeutics Inc The market for antibody therapeutics that bind CD47 is rapidly expanding, driven by the increasing demand for innovative treatments in the field of oncology and immune-related diseases. CD47, also known as the “don’t eat me” signal, is a protein that is overexpressed…
-
Invention for Antibody Therapeutics that Bind LAG3
Invented by Heyue Zhou, John Dixon Gray, Sorrento Therapeutics Inc The market for antibody therapeutics that bind LAG3 is rapidly growing, as researchers and pharmaceutical companies recognize the potential of targeting this immune checkpoint receptor in the treatment of various diseases, including cancer and autoimmune disorders. LAG3, also known as lymphocyte activation gene 3, is…